Pazopanib Hydrochloride

Pazopanib Hydrochloride

Send Inquiry

Pazopanib Hydrochloride

  • Each Film-Coated Tablet Contains 200 Mg Or 400 Mg Pazopanib (As Hydrochloride).
  • For The Full List Of Excipients, See Section 6.1.

Renal Cell Carcinoma (Rcc)

Votrient Is Indicated In Adults For The First Line Treatment Of Advanced Renal Cell Carcinoma (Rcc) And For Patients Who Have Received Prior Cytokine Therapy For Advanced Disease.

Soft Tissue Sarcoma (Sts)

Votrient Is Indicated For The Treatment Of Adult Patients With Selective Subtypes Of Advanced Soft Tissue Sarcoma (Sts) Who Have Received Prior Chemotherapy For Metastatic Disease Or Who Have Progressed Within 12 Months After (Neo) Adjuvant Therapy.

Efficacy And Safety Has Only Been Established In Certain Sts Histological Tumour Subtypes (See Section 5.1).